Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Asymchem Laboratories (Tianjin) Co., Ltd. Class H ( (HK:6821) ) has issued an update.
Asymchem Laboratories (Tianjin) Co., Ltd., a Hong Kong-listed pharmaceutical services provider, focuses on contract research and manufacturing to support global drug developers. Its business model centers on offering specialized laboratory and production capabilities to pharmaceutical and biotech customers, positioning it as a key partner in outsourced drug development.
The company announced a proposed final ordinary cash dividend of RMB 13 per 10 shares for the financial year ended 31 December 2025, subject to shareholder approval on 10 June 2026. The dividend, with Hong Kong dollar equivalent, exchange rate, key dates, and withholding tax details to be announced, is scheduled for payment on 24 July 2026, signaling continued shareholder returns and financial stability.
The most recent analyst rating on (HK:6821) stock is a Hold with a HK$90.00 price target. To see the full list of analyst forecasts on Asymchem Laboratories (Tianjin) Co., Ltd. Class H stock, see the HK:6821 Stock Forecast page.
More about Asymchem Laboratories (Tianjin) Co., Ltd. Class H
Asymchem Laboratories (Tianjin) Co., Ltd. is a Hong Kong-listed company in the pharmaceuticals and biotechnology services sector. It operates as a contract research and manufacturing organization, providing laboratory and production services that support drug development and commercialization for global biopharmaceutical clients.
Average Trading Volume: 298,824
Technical Sentiment Signal: Buy
Current Market Cap: HK$39.77B
Learn more about 6821 stock on TipRanks’ Stock Analysis page.